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        Approximately 50 million people in the United 
States have overt hypertension, and up to 60% 
of the population is prehypertensive (  1, 2  ). This 
is a major health care concern because hyper-
tension markedly increases the risk of death 
from stroke, ischemic heart disease, and other 
vascular diseases (  3  ). An important mediator of 
hypertension is the hormone angiotensin II, 
which increases thirst, promotes salt retention 
by the kidney, causes vasoconstriction, and en-
hances the release of catecholamines from nerves 
and the adrenal gland (  4  ). Angiotensin II also 
directly promotes infl  ammation and the devel-
opment of atherosclerosis (  5  ). Drugs that block 
the action of angiotensin II or prevent its for-
mation are generally eff  ective antihypertensive 
agents and, in some clinical trials, have reduced 
cardiovascular events in humans with athero-
sclerosis (  6  ). 
  There is substantial debate regarding the 
relative contributions of the vasculature, kidney, 
and central nervous system to the development 
of hypertension. In most cases of human hyper-
tension, systemic vascular resistance is increased, 
and genetically altered mice with increased vascu-
lar tone are hypertensive, suggesting that blood 
vessel constriction is a cause of hypertension 
(  7, 8  ). In keeping with this, potent vasodila-
tors, such as calcium channel antagonists, lower 
blood pressure in most humans with hyperten-
sion. In contrast to this direct vascular mech-
anism, angiotensin II injection into the third 
ventricle of the brain elevates blood pressure, 
and lesioning of neurons linking the forebrain to 
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  Hypertension promotes atherosclerosis and is a major source of morbidity and mortality. We 
show that mice lacking T and B cells (RAG-1      /      mice) have blunted hypertension and do 
not develop abnormalities of vascular function during angiotensin II infusion or desoxycor-
ticosterone acetate (DOCA)  –  salt. Adoptive transfer of T, but not B, cells restored these 
abnormalities. Angiotensin II is known to stimulate reactive oxygen species production 
via the nicotinamide adenosine dinucleotide phosphate (NADPH) oxidase in several cells, 
including some immune cells. Accordingly, adoptive transfer of T cells lacking the angiotensin 
type I receptor or a functional NADPH oxidase resulted in blunted angiotensin II  –  dependent 
hypertension and decreased aortic superoxide production. Angiotensin II increased T cell 
markers of activation and tissue homing in wild-type, but not NADPH oxidase  –  defi  cient, 
mice. Angiotensin II markedly increased T cells in the perivascular adipose tissue (periad-
ventitial fat) and, to a lesser extent the adventitia. These cells expressed high levels of CC 
chemokine receptor 5 and were commonly double negative (CD3    CD4       CD8       ). This infi  ltration 
was associated with an increase in intercellular adhesion molecule-1 and RANTES in the 
aorta. Hypertension also increased T lymphocyte production of tumor necrosis factor (TNF)     , 
and treatment with the TNF     antagonist etanercept prevented the hypertension and 
increase in vascular superoxide caused by angiotensin II. These studies identify a previously 
undefi  ned role for T cells in the genesis of hypertension and support a role of infl  ammation 
in the basis of this prevalent disease. T cells might represent a novel therapeutic target for 
the treatment of high blood pressure. 2450 T CELLS AND HYPERTENSION | Guzik et al.
resistance and elevate blood pressure. It has also been pro-
posed that O  2      ·      and related ROS can increase renal sodium 
reabsorption, which could also contribute to hypertension 
(  17  ). An NADPH oxidase is present in the circumventricular 
organs of the brain, and its stimulation in these sites contrib-
utes to hypertension (  18  ). It has been diffi   cult to understand 
how activation of the NADPH oxidases in these various or-
gans could aff  ect blood pressure in a concerted fashion. 
  T lymphocytes contain a functional NADPH oxidase and 
an AT1 receptor, and angiotensin II stimulates T cell prolif-
eration (  19, 20  ). Moreover, perturbation of immune function 
by thymectomy or by pharmacological interventions prevents 
hypertension in several experimental models (  21, 22  ). Infu-
sion of alloactivated T cells for treatment of cancer increases 
blood pressure in humans (  23  ). There is activation of both 
humoral and cellular immunity in women with preeclampsia 
(  24  ). Conversely, suppression of the adaptive immune system 
can inhibit hypertension in experimental animals and humans 
(  21, 25  –  27  ). Finally, a recent study has shown that patients 
with suppressed CD4 counts caused by human immunodefi  -
ciency virus infection have a low incidence of hypertension, 
but also that blood pressure is increased by highly aggressive 
antiretroviral therapy (  28  ). Collectively, these studies suggest 
that adaptive immunity contributes to hypertension via yet 
the brainstem cardiorespiratory center prevents many forms of 
experimental hypertension, indicating a neural etiology (  9  ). 
Finally, there is strong evidence that hypertension is solely 
caused by altered renal handling of salt and water. Transplan-
tation of kidneys lacking the angiotensin II type 1 (AT1) 
receptor into mice prevents hypertension caused by angio-
tensin II infusion (  10  ), and mutations of genes regulating 
sodium transport in the distal nephron of the kidney cause 
hypertension in humans (  11  ). These seemingly confl  icting ob-
servations provide a very confusing picture of the pathogenesis 
of hypertension, and a mechanism linking these various organs 
is lacking. 
  Recent studies have focused on a contribution of super-
oxide (O  2      ·     ) produced by the Nox-based nicotinamide aden-
osine dinucleotide phosphate (NADPH) oxidases. These are 
multisubunit enzymes that are similar to the neutrophil oxi-
dases that are present in vascular cells, kidney, and central 
nervous system (  12  ). Reactive oxygen species (ROS) pro-
duced by the Nox enzymes have been implicated in several 
models of experimental hypertension (  13, 14  ). Angiotensin II 
can activate these enzymes, and the O  2      ·      that is subsequently 
produced can react with the endogenous vasodilator nitric 
oxide (NO) at diff  usion-limited rates, thereby promoting 
vasoconstriction (  15, 16  ). This could increase systemic vascular 
  Figure 1.     Role of lymphocytes in development of angiotensin II  –  dependent hypertension. C57BL/6 and RAG-1      /      mice were treated for 14 d 
with 490 ng/min/kg angiotensin II, which was administered subcutaneously via osmotic minipump. (A) Noninvasive blood pressure measurements 
  obtained via the tail cuff method (  n   = 10 in each group). (B) Sample traces of telemetric systolic blood pressure recordings obtained in freely moving 
C57BL/6 and RAG1      /      mice showing the 3 d before angiotensin II pump implantation (control) and the last 3 d of angiotensin II infusion. (C) Mean values 
of invasive measurements of blood pressure at baseline and during angiotensin II infusion (  n   = 6  –  12). (D) Sample Western blots (top) and densitometric 
analysis (bottom;   n   = 4 in each group) for expression of AT1 and AT2 receptors in aortas of C57BL/6 and RAG-1      /      mice. *, P       0.01 vs. C57BL/6; 
 † ,  P       0.05 vs. sham. Data are expressed as the means       the  SEM.   JEM VOL. 204, October 1, 2007 
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C57BL/6 aortas (  Figs. 1 F  ). In keeping with this, the acute 
constrictor response to exogenous angiotensin II was similar 
in vessels of these animals (Fig. S1, available at http://www
.jem.org/cgi/content/full/jem.20070657/DC1). These data 
indicate that blunted hypertensive responses in RAG       /       
mice are not caused by diff  erences in angiotensin II receptor 
amount or signaling. A hallmark of hypertension is an in-
crease in vascular O  2      ·      production; however, in RAG-1       /       
mice, the vascular production of O  2      ·      was lower than that in 
C57BL/6 mice, both at baseline and after development of 
angiotensin II  –  induced hypertension (  Fig. 2 B  ). As previously 
reported, we found that chronic angiotensin II infusion impaired 
endothelium-dependent vasodilatation, but not endothelium-
independent vasodilatation in C57BL/6 mice (  Fig. 2 A  ).   In 
contrast, angiotensin II caused minimal perturbation of endo-
thelium-dependent vasodilatation in RAG-1      /       mice ( Fig. 2 A ). 
Angiotensin II also causes vascular hypertrophy in animals and 
humans (  29, 30  ). This was signifi  cantly blunted in RAG-1       /       
compared with C57BL/6 mice (  Fig. 2 C  ). Thus, many of 
the vascular consequences of angiotensin II were prevented in 
mice lacking lymphocytes. 
  To determine if the reduced hypertensive response in 
RAG-1       /       was specifi  c to angiotensin II, we also studied des-
oxycorticosterone acetate (DOCA)-salt hypertension, which 
is characterized by low levels of circulating angiotensin II. 
undefi  ned mechanisms. In this study, we demonstrate that 
the T lymphocyte, particularly the AT1 receptor and the 
NADPH oxidase in T cells, is required for the full develop-
ment of hypertension. The adventitia and periadventitial fat of 
vessels from hypertensive mice contain increased amounts of 
lymphocytes and an inordinate proportion of CD3     /CD4        /
CD8        /CD44  high  /CC chemokine receptor (CCR) 5      cells. 
Our data indicate that peripheral blood T cells are activated to 
produce TNF     , IFN     , and to express tissue-homing receptors 
upon angiotensin II infusion. Blockade of TNF      normalized 
blood pressure and vascular O  2      ·      production in angiotensin II  – 
infused animals. Thus, this study identifi  es a previously un-
known role of the T lymphocyte in the development of hy-
pertension and related vascular abnormalities. 
    RESULTS   
  Role of T lymphocytes in modulation of blood pressure 
and vascular function 
  Using both the noninvasive tail cuff   method and invasive 
monitoring with indwelling catheters, we found that the hy-
pertension caused by chronic low-dose angiotensin II infu-
sion was markedly blunted in mice with genetic deletion of 
the recombinase-activating gene (RAG; RAG-1       /       mice), 
which lack both T and B lymphocytes (  Fig. 1  ).   Expression 
of AT1 and AT2 receptors was similar in RAG1       /       and 
  Figure 2.     Role of lymphocytes in the development of vascular dysfunction and hypertrophy in angiotensin II  –  dependent hypertension. 
(A) Effect of angiotensin II  –  induced hypertension on endothelium-dependent vasodilatation to acetylcholine (Ach) in aortas of C57BL/6 (  n   = 6) and 
RAG-1      /      ( n   = 9) mice (left). Relaxations to sodium nitroprusside (SNP) were examined as a measure of nonendothelium-dependent vasodilatation (right). 
(B) Aortic superoxide levels measured by monitoring the oxidation of dihydroethidium to 2-hydroxyethidium using high pressure liquid chromatography 
after 14 d of angiotensin II infusion (  n   = 8  –  10). (C) Effect of angiotensin II  –  induced hypertension on aortic hypertrophy in C57BL/6 (  n   = 6 in each group) 
and RAG-1      /      ( n   = 6 in each group) mice measured as wall thickness (top left) and by total wall area determined by planimetry (bottom left) in hematoxylin-
eosin  –  stained sections of thoracic aorta. Sample sections are shown on the right. *, P       0.01 vs. C57BL/6;   †  , P       0.05 vs. sham. Data are expressed 
as the means       the SEM. Bar, 50     m.   2452 T CELLS AND HYPERTENSION | Guzik et al.
was blunted after adoptive transfer of T cells from mice lacking 
the oxidase subunit p47    phox     compared with wild-type T cell  –
  reconstituted mice (  Fig. 4, B and C  ). 
  Vascular T cell infi  ltration in hypertension 
  To gain insight into how T cells might contribute to hyper-
tension and vascular dysfunction, we examined the eff  ect of 
angiotensin II to promote vascular infi  ltration of T cells. We 
observed that the number of circulating CD4      lymphocytes 
expressing the hyaluronan receptor CD44 and the chemo-
kine receptor CCR5 was signifi  cantly increased in C57BL/6 
mice after 2 wk of angiotensin II infusion (  Fig. 5 A  ).   Nota-
bly, angiotensin II also stimulated vascular expression of the 
CCR5 ligand RANTES (  Fig. 5 B  ). T cell expression of 
CD62L and CD11b, which promote T cell infi  ltration into 
the vessel wall in atherosclerosis (  32  ), were not aff  ected by 
angiotensin II treatment (unpublished data). In other studies, 
we confi  rmed prior observations that angiotensin II stimu-
lated aortic levels of the intracellular adhesion molecule 
(ICAM)-1, although not changing expression of the vascular 
adhesion molecule-1 (Fig. S2, available at http://www.jem
.org/cgi/content/full/jem.20070657/DC1) (  33  ). The coor-
dinated actions of angiotensin II to induce the hyaluronan 
receptor, which increases T cell interaction with the vascular 
endothelium, CCR5, and its vascular ligand, could predis-
pose to vascular infi  ltration of T cells. Indeed, using immuno-
staining for CD3 and immunofl  uorescence for the T cell 
receptor, we found that angiotensin II markedly increased 
the number of T cells in the aortic adventitia, particularly in 
the periadventitial fat (  Fig. 5 C  ). This was confi  rmed using 
real-time PCR for aortic CD3 mRNA (  Fig. 5 D  ) and by 
FACS analysis of cell suspensions of collagenase-digested 
aortas (  Fig. 6, A and B  ).   Total leukocytes were also substantially 
increased by angiotensin II infusion (  Fig. 6 B  ). Flow cyto-
metric analysis further revealed that angiotensin II increased 
aortic content of CD4      and, to a lesser extent, CD8      lym-
phocytes (  Fig. 6 B  ). Notably, 30% of aortic CD3      cells were 
negative for both CD4 and CD8 (  Fig. 6 C  ), and the total 
number of aortic double-negative (DN) T cells was increased 
    7-fold by angiotensin II (  Fig. 6 D  ). Interestingly, the per-
centage of aortic DN T cells expressing      /     , as opposed to 
     /     , T cell receptors, increased from 35       2 to 51       9% 
(  n   = 6 each) during angiotensin II infusion. Analysis of periph-
eral blood revealed that only 5.1       0.6% of circulating T cells 
were DN in sham-treated mice (  n   = 6; P       0.001 vs. aorta), 
and that this was increased by angiotensin II infusion to 7.6       
0.5% (  n   = 6; P       0.005). Another unique feature of vascular 
T cells in both sham and angiotensin II  –  treated mice was that 
a very high percentage expresses CCR5, compared with 
circulating T cells (  Fig. 6 E  ). 
  Role of the NADPH oxidase in T cell activation caused 
by angiotensin II 
  As shown in   Fig. 3 B  , the T cell NADPH oxidase is necessary 
for full development of angiotensin II  –  induced hypertension. 
In keeping with this, we found that activation of T cells by 
The increase in blood pressure in this model was also blunted 
in RAG-1       /       mice, indicating that lymphocytes likely play 
a role in other causes of hypertension than angiotensin II 
(  Fig. 3 A ).   Moreover, vascular O  2      ·      production was also blunted 
in RAG1       /       mice with DOCA-salt hypertension (  Fig. 3 B  ). 
  Using negatively selected lymphocyte subtypes, we re-
stored either the T or B cell population in RAG-1       /       mice 
(  Fig. 4 A  ).   Adoptive transfer of B cells into RAG-1       /       mice 
had little eff  ect on the increase in blood pressure or vascular 
O  2      ·      production caused by angiotensin II (  Fig. 4, B and C  ). 
In contrast, adoptive transfer of T cells restored the hyperten-
sion and increased vascular O  2      ·      levels in response to angio-
tensin II (  Fig. 4, B and C  ). Likewise, acetylcholine-mediated 
vasodilatation was impaired by angiotensin II in mice after 
T cell adoptive transfer (  Fig. 4 D  ). These data indicate that 
the T lymphocyte plays a critical role in the development of 
hypertension, vascular O  2      ·      production, and vascular dys-
function caused by angiotensin II. The hypertensive eff  ect of 
angiotensin II can be inhibited by blockade of the angioten-
sin type AT1 receptor. We found that this could be caused, 
in part, by blockade of the T cell AT1 receptor, as adoptive 
transfer of T cells from AT1a       /       mice only partially restored 
the angiotensin II  –  induced hypertensive response (  Fig. 4, 
B and C  ). In several tissues, the AT1a receptor signals activation 
of the NADPH oxidase (  31  ). In keeping with this, the increase 
in blood pressure and vascular O  2      ·      caused by angiotensin II 
  Figure 3.     Role of lymphocytes in development of DOCA-salt  –
    induced hypertension and vascular oxidative stress. C57BL/6 and 
RAG-1      /      mice were subjected to DOCA-salt hypertension for 40 d. 
(A) Noninvasive blood pressure measurements were obtained via the tail 
cuff method (  n   = 5  –  6) in DOCA-salt  –  induced hypertension and in sham-
operated C57BL/6 (  n   = 5) and RAG1      /      ( n   = 6) mice. (B) Aortic superoxide 
levels measured by monitoring the oxidation of dihydroethidium to 
2-hydroxyethidium using high pressure liquid chromatography after 40 d of 
DOCA-salt hypertension (  n   =  8 – 10).  *,  P        0.01 vs. C57BL/6;   †  , P       0.05 
vs. sham. Data are expressed as the means       the  SEM.   JEM VOL. 204, October 1, 2007 
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of other cytokines by T cells, including IL-2, -4, and -5 as 
measured with cytometric bead array were not signifi  cantly 
altered by angiotensin II. This is likely caused in part by a 
direct action on the T cell, because in vitro angiotensin II 
augmented production of TNF      in response to anti-CD3 
(  Fig. 8 B  ). To determine if the increase in TNF      and IFN      
were of pathophysiological signifi  cance, C57BL/6 mice were 
treated with either the soluble TNF      receptor etanercept or 
a neutralizing anti-IFN      antibody during the angiotensin II 
infusion. Etanercept prevented the hypertension and mark-
edly reduced the increase in vascular O  2      ·      production caused 
by angiotensin II (  Fig. 8, C and D  ), whereas the anti-IFN      
antibody was without signifi  cant eff  ect (not depicted). 
    DISCUSSION   
  In this study, we show that the T cell plays an important role 
in the genesis of hypertension. RAG-1       /       mice lacking 
T and B cells demonstrated a blunted blood pressure increase 
to both angiotensin II infusion and DOCA-salt hypertension, 
a model in which circulating angiotensin II levels are suppressed 
(  34  ). Adoptive transfer of T cells, but not B cells, restored the 
hypertensive response to angiotensin II in RAG-1       /       mice. 
Both in vivo and, to a lesser extent, in vitro, angiotensin II 
augmented CD69 expression, which is an early marker of 
angiotensin II was dependent on the NADPH oxidase. In vitro, 
incubation of T cells with angiotensin II alone had no eff  ect 
on T cell activation as measured by CD69 surface expression. 
However, coincubation with angiotensin II augmented anti-
CD3  –  induced expression of this marker at 3 h (  Fig. 7 A  ).  This 
response was completely prevented by the NADPH oxidase 
inhibitor apocynin (  Figs. 7 A  ). In vivo, the increase in CD69, 
CCR5, and CD44 caused by angiotensin II was diminished 
in p47    phox           /       mice (  Fig. 7 B  ). Similarly, aortic T cell infi  ltra-
tion, as quantifi  ed by real time PCR for CD3 mRNA was 
absent in p47    phox           /       mice (  Fig. 7 C  ). Importantly, angiotensin 
II infusion increased T cell expression of the NADPH oxi-
dase subunits p47    phox    , p22    phox    , and No  x  2 (  Fig. 7 D  ). This was 
accompanied by a striking increase in the ability of T cells to 
produce O  2      ·      (  Fig. 7 E  ). 
  Effect of cytokine blockade on angiotensin II  – 
induced hypertension 
  The T cell NADPH oxidase has recently been shown to 
aff   ect cytokine production, which in turn might mediate 
hypertension and vascular dysfunction. Accordingly, we ob-
served that T cell production of TNF      and IFN      was in-
creased after 2 wk of angiotensin II infusion in wild-type, but 
not in p47    phox           /       mice (  Fig. 8 A  ).   In contrast, the production 
  Figure 4.     Comparison of the role of B and T lymphocytes in modulation of blood pressure and vascular function in response to angiotensin II  –
  mediated hypertension using adoptive transfer. RAG-1      /      mice received either no cells (saline;   n   = 4), B cells (  n   = 4), wild-type T cells (  n   =  10), 
or T cells from mice lacking AT1a receptors (  n   = 6) or from mice lacking p47  phox   NADPH oxidase subunit (  n   = 4). 3 wk after this, osmotic minipumps for 
angiotensin II infusion were surgically implanted. (A) Flow cytometric analysis of lymphocyte surface markers from C57BL/6 and RAG-1      /      mice at baseline 
and 3 wk after adoptive transfer of T and B lymphocytes. (B) Blood pressures at baseline and after angiotensin II infusion measured by tail cuff. (C) Aortic 
O  2   ·     levels after angiotensin II infusion. (D) Endothelium-dependent vasodilatation to acetylcholine and sodium nitroprusside after angiotensin II infusion. 
*, P       0.01 vs. C57BL/6;   †  , P       0.01 vs. sham; #, P       0.01 vs. RAG-1      /     . Data are expressed as the means       the  SEM.   2454 T CELLS AND HYPERTENSION | Guzik et al.
to produce IL-17, which is a potent proinfl  ammatory cyto-
kine involved in autoimmune disorders (  37  ). Therefore, the 
     /     DN T cells observed in the periaortic tissues in this study 
could participate in vascular infl  ammatory responses. Our 
fi  ndings regarding leukocyte infi  ltration are in keeping with 
prior reports in spontaneously hypertensive rats (  38, 39  ). 
  Because vascular T cells are CCR5      and CD44  high  , they 
have the phenotype of eff  ector T cells. Such cells have a low 
activation threshold, produce TNF      and IFN     , and could 
contribute to vascular dysfunction and hypertension (  40  ). A 
potentially important fi  nding is the localization of T cells to the 
perivascular fat. It has recently been recognized that activated 
eff  ector CD4      cells migrate to nonlymphoid tissue, includ-
ing fat (  41  ). Moreover, Wu et al. have recently shown that 
fat feeding of mice increases expression of RANTES in adi-
pose tissue, and that this is associated with T cell accumulation. 
In this study, the authors also showed a correlation between 
CCR5 and RANTES mRNA in fat and body mass index in 
humans (  42  ). There has been increasing interest in the role of 
visceral adipose tissue as a source of cytokines and systemic 
infl  ammation (  43, 44  ). It is interesting to speculate that the 
increase in visceral adipose tissue in humans with the metabolic 
syndrome leads to accumulation of perivascular fat, which in 
turn serves as a reservoir for activated eff  ector T cells, which 
in turn promote vascular dysfunction and hypertension. This 
might, in part, explain the common coexistence of visceral obe-
sity and hypertension and also provide insight into why weight 
loss commonly leads to blood pressure reduction (  45  ). 
  Our studies show that T cells are important in the altera-
tion of vascular tone encountered in angiotensin II  –  induced 
hypertension. Infi  ltration of T cells in other tissues might also 
be important in the development of hypertension. In prelim-
inary studies, we found a modest degree of T cell infi  ltration 
in the kidneys of angiotensin II  –  infused animals. Analogous 
to the situation in vessels, the balance between NO and O  2      ·      
in the renal medulla aff  ects the tone of the vasa recta, which 
in turn modulates sodium and water and aff  ects blood pres-
sure (  46  –  48  ). Similarly, T cell infi  ltration into adrenal glands, 
could aff  ect regulation of blood pressure. In preliminary stud-
ies using RT-PCR, we have found the levels of CD3 mRNA 
to be 20-fold lower in the adrenals compared with the aortas, 
but they are doubled by angiotensin II infusion. Additional 
studies are needed to defi  ne the importance of this fi  nding. 
  It has previously been reported that angiotensin II can 
promote T cell proliferation (  20  ). Our experiments with 
adoptive transfer of AT1a receptor  –  defi  cient T cells indicate 
that at least some of the hypertensive eff  ect of angiotensin II 
is caused by its direct action on T cells. The hypertensive 
response that remained after adoptive transfer of AT1a       /       T 
cells is almost certainly caused by actions on other cells, which 
in turn might interact with T cells. For example, angiotensin II 
stimulates dendritic cell migration, CCR7 expression, and 
diff  erentiation, which in turn promotes T cell activation (  25  ). 
It is also possible that oxidatively modifi  ed lipoproteins or 
fatty acids released from fat cells surrounding the vessels gain 
antigenic properties and are presented by dendritic cells to 
T cell activation. In vivo, angiotensin II exerted a coordi-
nated eff  ect on T cells to increase the tissue-homing proteins 
CD44 and CCR5 and on vessels to increase levels of the 
CCR5 ligand RANTES. In accordance with these molecular 
events, angiotensin II caused a striking infi  ltration of T cells 
into the periadventitial fat and adventitia. Our data also indi-
cate that angiotensin II increases T cell production of TNF     , 
and that blockade of TNF      prevents the hypertension and 
increase in vascular O  2      ·      production caused by angiotensin II. 
These studies identify a yet to be unidentifi  ed role of the 
T cell in modulation of blood pressure  –   and hypertension-
related vascular dysfunction. 
  An important fi  nding in this study is that angiotensin II 
exerts dual eff  ects on T cells and vessels, increasing CD44 
and CCR5 in the former and RANTES in the latter. These 
events would favor vascular accumulation of T cells and, 
indeed, we found that CD4      and, to a lesser extent, CD8      
T cells preferentially accumulate in the adventitia and periad-
ventitial fat of hypertensive animals. Notably,     30% of T 
cells present in this site lack both CD4 and CD8. Under nor-
mal circumstances, DN T cells compose no more than 5% of 
circulating T cells. More commonly, DN cells possess      /      
T cell receptors, and have been suggested to act as regulatory 
T cells (  35  ). Recently, it has been shown that        DN cells are 
proinfl  ammatory, and that they are increased in humans with 
cutaneous leishmaniasis (  36  ). DN T cells have been reported 
  Figure 5.     T cell homing and vascular infi  ltration in response to 
angiotensin II  –  induced hypertension. (A) The percentage of circulating 
CD4      lymphocytes expressing CCR5 and high levels of CD44, as deter-
mined by fl  ow cytometric analysis (  n   = 10). (B) Aortic mRNA expression 
of the CCR5 ligand RANTES, as determined by real time PCR (  n   =  6). 
(C) Immunostaining of aortas from sham-treated and angiotensin II  –  infused 
C57BL/6 mice using anti-CD3 (top) and a fl   uorescent  anti – TCR  antibody 
(representative of   n   = 4  –  6 experiments). (D) Aortic CD3 (      chain)  mRNA 
determined by real-time PCR in sham-treated and angiotensin II  –  infused 
C57BL/6 (  n   = 6 in each group). *, P       0.05 vs. sham. Data are expressed as 
the means       the SEM. Bar, 20     m.   JEM VOL. 204, October 1, 2007 
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such that blockade of any one of these might prove eff  ective. 
In keeping with a role of O  2      ·      in modulating NO bioavail-
ability, parallel fi  ndings were observed for endothelium-
dependent vasodilatation, such that angiotensin II caused only 
a minor alteration of endothelial function in RAG-1       /       mice. 
In contrast, after adoptive transfer of T cells to these animals, 
angiotensin II infusion caused a markedly altered vascular 
relaxation response. 
  In addition to angiotensin II  –  induced hypertension, the 
increase in blood pressure caused by DOCA-salt hypertension 
was also blunted in RAG-1       /       mice. In preliminary studies, 
we also found that DOCA-salt hypertension increases circu-
lating T cells containing CD69 and CCR5, which is similar 
to the situation during angiotensin II  –  induced hypertension. 
DOCA-salt hypertension is associated with suppressed plasma 
renin and angiotensin II levels (  53  ), suggesting that the lack 
of T cells likely plays a role in several forms of hypertension. 
We chose these two models because angiotensin II  –  induced 
hypertension is, at least in part, mediated by vasoconstriction, 
whereas the DOCA-salt model is completely independent of 
vascular tone (  54, 55  ). 
activate T cell receptors (  49, 50  ). Finally, angiotensin II could 
augment immune responses to pathogens normally encoun-
tered from the skin and gut, linking those common infl  am-
matory processes to hypertension. 
  It is interesting that vascular O  2      ·      levels were reduced in 
RAG-1       /       mice, and that after adoptive transfer of T cells, 
there was normalization of these values, suggesting that T 
lymphocytes play a crucial role in modulating vascular O  2      ·      
production. Because our measurements of vascular O  2      ·      were 
made in segments of vessels in which the adventitia and peri-
adventitial fat were carefully dissected from the vessel, this is 
probably not because our measurements of O  2      ·      refl  ect T cell 
production of this radical. A more plausible explanation is 
that cytokines released from T cells in the periadventitial fat, 
such as TNF     , stimulate the NADPH oxidase in the vascular 
smooth muscle (  51, 52  ). Indeed, when we cotreated mice 
with etanercept, this not only prevented hypertension but also 
markedly blunted the increase in vascular O  2      ·      production. It 
is possible that the combination of TNF     , angiotensin II, and 
perhaps catecholamines released in response to angiotensin II 
serves as a prooxidant milieu to activate the vascular oxidase, 
  Figure 6.     Characteristics of T cells infi  ltrating the aorta in response to angiotensin II  –  induced hypertension. (A) Examples of fl  ow cytometric 
analysis of collagenase-digested cell suspensions of sham- and angiotensin II  –  infused mouse aortas. Fluorescent staining was performed to detect CD45 
(total leukocytes) and CD3 (T cells). (B) Absolute numbers of total leukocytes (CD45     , top left), total T cells (CD3     , bottom left), and CD4+ and CD8+ sub-
classes (right) in whole aortas from sham- (open bars) and angiotensin II  –  infused mice (fi  lled bars;   n   = 9). Insert shows the alteration of CD4/CD8 index 
caused by angiotensin II infusion. (C) Sample fl  ow cytometric analysis and (D) absolute numbers of total DN (CD3+CD4-CD8-) T cells in single-cell sus-
pensions from aortas of sham-infused (  n   = 9) and angiotensin II  –  treated mice (  n   = 9). CD4  and CD8  cells were both labeled with PerCP, and CD3  
cells were labeled with APC. DN T cells were gated based on control experiments in which isotype antibody control (PerCP) was added instead of anti-CD4 
and -CD8. (E) Percentage of CCR5      T cells in the aorta, peripheral blood, and spleen of sham-treated (  n   = 5) and angiotensin II  –  infused mice (  n   =  5). 
Inset shows sample histograms of the CCR5 expression within the CD3      gate. *, P       0.05 vs. sham;   †  , P       0.01 vs. aorta. Data are expressed as the 
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as can alterations in T cell redox status (  19, 60  ). In keeping 
with this, adoptive transfer of T cells that lack p47    phox    , which 
is a critical cytosolic subunit of the oxidase, only partially re-
stored the hypertensive response to angiotensin II in RAG-1       /       
mice, and it eliminated the increase in vascular O  2      ·      caused 
by angiotensin II. 
  Etanercept prevented the hypertension and blunted the 
increase in O  2      ·      caused by angiotensin II, supporting a role of 
TNF      in the genesis of angiotensin II. Etanercept has been 
shown to prevent renal damage in genetically hypertensive 
rats and to lower blood pressure in rats with hypertension 
  induced by angiotensin II and salt (  25, 61  ). A recent study has 
shown that etanercept reduced pulse wave velocity and im-
proved endothelium-dependent vasodilatation in patients with 
rheumatoid arthritis (  62  ). 
  These fi  ndings, together with prior studies, indicate that 
the NADPH oxidase contributes to the pathophysiology of 
hypertension in several organs. In the circumventricular or-
gans, the NADPH oxidases promote sympathetic outfl  ow 
  Blood pressure in RAG       /       mice was not lower than 
C57BL/6 mice under basal conditions, indicating that T cells 
do not modulate hemodynamics in the absence of a patho-
physiological stimulus. The modulation of blood pressure under 
normal conditions is complex and involves an interaction of 
the central nervous system, the kidney, the adrenals, and the 
vasculature (  56  ). Moreover, there are buff  er mechanisms such 
as the carotid barorefl  ex, the phenomenon of pressure natri-
uresis, and adaptive changes in vascular gene expression that 
compensate for modest fl  uctuations in blood pressure (  57  –  59  ). 
Our data indicate that the infi  ltration of T cells overcomes 
these compensatory mechanisms. 
  Our data also implicate a role of the T cell NADPH oxi-
dase in hypertension and T cell activation and tissue homing. 
In wild-type mice, angiotensin II  –  induced hypertension caused 
an increase in expression of most subunits of the T cell 
NADPH oxidase and markedly increased the ability of T cells 
to produce O  2      ·     . It has previously been reported that the 
NADPH oxidase can modulate T cell cytokine production, 
  Figure 7.     Role of the T lymphocyte NADPH oxidase in modulating T cell activation, tissue homing, and blood pressure in response to angio-
tensin II. (A) Effect of 100 nM angiotensin II on the early activation marker CD69 in cultured T cells exposed to anti-CD3 (  n   = 5). Parallel experiments 
were performed in the presence of the NADPH oxidase inhibitor apocynin (300     M/liter;   n   = 4). (B) Role of the NADPH oxidase on angiotensin II modulation 
of CD4     CD69, CCR5, and CD44 expression, as determined using fl  ow cytometry. Experiments were performed in C57BL/6 and p47    phox       /      mice. (C) Role of 
the NADPH oxidase in modulating aortic T cell infi  ltration, as determined by levels of       chain CD3 mRNA. Measurements were obtained in sham and 
angiotensin II  –  infused mice. (D; left) Western blots examining NADPH oxidase cytosolic (p47  phox   and  p67 phox  ) and membrane (p22  phox   and  gp91 phox )  subunits 
in isolated T cells from sham-infused and angiotensin II  –  treated mice. Purity of T cell preparations was      98% as determined by fl  ow cytometry, and it did 
not differ between groups. (right) Densitometric analysis of four separate experiments. (E) T cell production of O  2   ·     determined by electron spin resonance 
at baseline and in response to the phorbol ester PMA in T cells from sham and angiotensin II  –  infused mice. (left) Sample time scans of the low fi  eld peak 
of the CAT1-H spectra; (right) mean data from fi  ve experiments. *, P       0.05 vs. sham;   †  , P       0.02 vs. C57BL/6; #, P       0.05 PMA vs. basal;   ¶  , P       0.03  vs. 
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angiotensin II was infused and blood pressure was measured both invasively 
and noninvasively, as previously described (  69  ). Animals were maintained in 
a sterile environment and were regularly screened for infections. For adop-
tive transfer, mice were anesthetized with xylazine/ketamine and cells were 
injected via tail vein. Angiotensin II infusion and blood pressure monitoring 
was begun 3 wk after adoptive transfer. In some experiments, 8 mg/kg etan-
ercept (AmGen) or a neutralizing IFN      antibody (eBioscience; clone R4-6A2; 
0.5 mg per injection per 30 g mouse) was administered i.p. 3 d before and 
every 3 d during angiotensin II infusion. In some mice, DOCA-salt hyper-
tension was created as previously described, and studies were performed after 
40 d from the induction of hypertension (  14  ). 
  Flow cytometry.     Spleens were removed and tissue-disrupted using forceps 
to release a single-cell suspension, which was passed through a 70-     m sterile 
strainer. Total blood leukocytes were isolated from the whole heparinized 
blood after osmotic lysis of excess red blood cells. Cells were centrifuged 
(800   g  ), washed twice with PBS and 0.5% BSA (FACS buff  er), counted, 
resuspended in 1% BSA/PBS, and stored on ice for      30 min. Within 30 min, 
10  6   cells were stained for 15 min at 4  °  C with antibodies and washed twice 
with FACS buff  er. Antibodies used for staining, and in diff  erent multicolor 
combinations, are as follows: FITC anti-CD45 (30-F11); PerCP anti-CD45 
(30-F11); APC anti-CD19 (1D3); PE anti-CD4 (GK1.5); APC anti-CD4 
(GK1.5); FITC anti-CD4 (GK1.5); PerCP anti-CD8 (53  –  6.7); APC anti-
CD3 (145-2C11); PE anti-I-Ab (AF6-120.1); FITC anti-I-Ab (AF6-120.1); 
APC anti-CD11b (HL3); APC CD11b (M1/70); PE 62L (MEL-14); PE 
CD25 (PC61); APC CD4 (RM4-5); PerCP CD4 (RM4-5); PE CCR5; 
FITC      /      (GL3); FITC V     7; FITC CD44 (IM7); FITC CD69 (H1.2F3); 
PE TcR       chain (H57-597); PE CD19 (1D3); and PE NK1.1 (PK136). 
  After immunostaining, cells were resuspended in FACS buff  er and ana-
lyzed immediately on a LSR-II fl  ow cytometer with DIVA software (Becton 
Dickinson). Data were analyzed with FlowJo software (Tree Star, Inc.). T cells 
were analyzed as a percentage of the PBMC, and they were also expressed in 
absolute numbers. 
  Analysis of leukocytes in vessels.     Mouse aortas were digested using col-
lagenase type IX (125 U/ml), collagenase type IS (450 U/ml), and hyal-
uronidase IS (60 U/ml) dissolved in 20 mM Hepes-PBS buff  er containing 
calcium and magnesium for 30 min at 37  °  C, with constant agitation. Aortas 
were then passed through a 70-     m sterile cell strainer (Falcon; BD Bio-
sciences), yielding single-cell suspensions. Cells were washed twice with 
1% BSA PBS buff  er and additionally incubated for 30 min in 37  °  C with 
complete media (RPMI; 10%FCS), then washed again, counted, and stained, 
using multicolor fl  ow cytometry as described in the previous paragraph. An 
initial gate was applied to exclude cell debris from further analysis (  Fig. 6 A  ), 
and CD45 staining was used to identify leukocytes within the aortic cell 
  suspension. Within the CD45      gate, T cells were identifi  ed with anti-CD3, 
-CD4, and -CD8 antibodies, as well as antibodies to detect other supple-
mentary surface molecules. 
  Aortic T cell infi  ltration was confi  rmed by real time PCR using specifi  c 
primers to detect CD3       (forward, CGTCCGCCATCTTGGTAGAGA-
GAGCAT; reverse, CTACTGCTGTCAGGTCCACCTCCAC). Longer 
PCR product encompassing above sequences was used as standard. 
  T and B cell separation.     For purifi  ed T or B cell separation, splenocytes 
or PBMC were isolated from donor mice and were purifi  ed using autoMACS 
and either a Pan T or B cell isolation kit (Miltenyi Biotech). Cell purity was 
confi  rmed to be      95%. 
  Adoptive transfer of purifi  ed T or B cells.     Adoptive transfer was per-
formed 3 wk before angiotensin II infusion. In preliminary studies, we found 
that longer delays after adoptive transfer had only minimal eff  ect in either 
splenic or circulating T cell number. Total splenocytes were isolated from 
donor mice, and either T or B cells were isolated using cell-specifi  c isolation 
kits (Miltenyi Biotech) and negative magnetic sorting (AutoMACS), yielding 
sterile and highly enriched T or B cells. The purity of these was confi  rmed 
and hypertension (  63  ). T cell  –  rich regions of lymph nodes 
and the spleen are innervated by sympathetic nerves, and 
sympathetic nerve stimulation promotes T cell activation 
(  64  –  66  ). In T cells, the NADPH oxidase contributes to their 
activation, cytokine production, and tissue homing (  19, 67  ). 
Our studies indicate that activated T cells stimulate the vascu-
lar production of O  2      ·     , which is dependent on the NADPH 
oxidase and promotes hypertension (  15, 68  ). In this regard, 
the T cell likely plays a central role in modulation of hyper-
tension and provides a new therapeutic target for treatment 
of this common disease. 
    MATERIALS AND METHODS   
  Animals.     C57BL/6, RAG-1       /      , and AT1a       /       mice were obtained from 
Jackson ImmunoResearch Laboratories. The p47    phox           /       mice and their ap-
propriate controls were obtained from Taconic. All experimental protocols 
were approved by the institutional Animal Care and Use Committee at 
Emory University. All mice were on a C57BL/6 background. 490 ng/min/kg 
  Figure 8. Role of cytokines in blood pressure regulation and vascular 
O  2      ·     production. (A) Production of TNF-      (top) and IFN-      (bottom) 
measured by cytometric bead array from anti-CD3  –  stimulated peripheral 
blood T cells isolated from C57BL/6 and p47  phox    /      mice infused with 
saline (sham) or angiotensin II for 14 d (  n   = 8 in each group). (B) Anti-
CD3 – stimulated  production  of  TNF-     from spleen-derived T cells in 
response to in vitro coincubation without (vehicle;   n   = 6) or with 100 nm 
angiotensin II (Ang II;   n   = 6). (C) Noninvasive blood pressure measurements 
at baseline and during angiotensin II infusion measured by tail cuff 
in mice injected IP with control IgG (  n   = 4) or with anti-TNF      therapy 
(etanercept, ETA; 8 mg/kg;   n   = 6) 3 d before and every 3 d throughout the 
experiment. (D) Aortic O  2   ·     levels after angiotensin II infusion in control 
mice or mice injected with etanercept (  n   = 6) compared with sham-
  infused mice. In preliminary experiments, we showed that ETA did not 
directly inhibit contraction of vascular rings in response to angiotensin II. 
*, P       0.05 vs. sham;   ¶  , P       0.05 vs.      -CD3 + vehicle using a paired one-
tailed   t   test;   †  , P       0.05 vs. control Ig; #, P       0.01 vs. Ang II alone. Data 
are expressed as the means       the  SEM.   2458 T CELLS AND HYPERTENSION | Guzik et al.
was then performed using an LSR II (BD Biosciences) and FlowJo Software 
(Tree Star, Inc.). 
  To analyze the eff  ect of angiotensin II on cytokine production by iso-
lated T lymphocytes, cells were plated at a density of 2       10  5   per well 
in 96-well plates precoated with anti-CD3 and cultured for 48 h at 37  °  C 
with 5% CO  2  . After the incubation period, the media were collected and 
analyzed using the Cytometric Bead Array (BD Biosciences) to measure 
secreted TNF-     . 
  Statistics.     All data are expressed as the means       the SEM. Comparisons 
between groups of animals or treatments were made by one-way ANOVA, 
followed by either the Student-Newman-Keuls or Bonferroni tests when 
specifi  c comparisons were desired. Analysis of dose  –  response curves for vas-
cular studies was performed using ANOVA for repeated measures. Values of 
P       0.05 were considered statistically signifi  cant. 
  Online supplemental material.     To determine if reduced hypertensive re-
sponses to angiotensin II in Rag       /       mice could be caused by blunted vascu-
lar contractions, abdominal aortic rings from C57BL/6 and RAG1       /       mice 
were exposed to 100 nM angiotensin II (Fig. S1). We also studied the eff  ect 
of angiotensin II on aortic expression of the adhesion molecules ICAM-1 
and vascular adhesion molecule-1 (Fig. S2). The online version of this article 
is available at http://www.jem.org/cgi/content/full/jem.20070657/DC1. 
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to be       95% by fl  ow cytometry before injection. Immediately after the cell 
isolation, 2       10  7   cells were resuspended in 150      l of sterile PBS, passed 
through a 70-     m fi  lter, and injected into RAG-1       /       mice via tail vein. 
Successful adoptive transfer was confi  rmed at the time of sacrifi  ce using fl  ow 
cytometry. 3 wk after adoptive transfer of T cells, the number of T cells in 
the spleen of RAG1       /       mice averaged 2.6       0.3       10  6  . B cell adoptive 
transfer resulted in a total of 1.1       0.10  7   B cells per spleen. 
  Cytokine determinations.     Cytokines were quantifi  ed in the media after 
48 h of culture of isolated T cells in anti-CD3 antibody  –  coated plates (BD 
PharMingen). Cells were cultured in 96-well plates T cells were plated at a 
density of 2       10  5   per well. Cytometric Bead Array (BD PharMingen) was 
used according to the manufacturer  ’  s recommendations, which allowed for 
simultaneous determination of TNF-     , IFN-     , IL-2, IL-4, and IL-5. 
  To determine aortic RANTES expression, SYBR green real time PCR was 
used using specifi  c primers (forward, 3     -TGCTCCAATCTTGCAGTCGT-5     ; 
reverse, 3     -GCGTATACAGGGTCAGAATCAAG-5     ). A longer PCR prod-
uct encompassing this target sequence was used as standard. 
  Immunohistochemistry and immunofl  uorescence.     For immunohisto-
chemistry, mice were initially perfused with saline, and then with 10% 
  formalin. After tissue processing, the aorta was embedded in paraffi   n. 5-     m 
sections of the aorta were prepared from the thoracic aorta segments 1 mm 
above the diaphragm. After deparafi  nization, antigen retrieval was performed 
in citrate buff  er, pH 6.0. Blocking was sequentially performed with 2% BSA, 
normal horse serum (Vector Laboratories), with avidin-biotin block (SP-
2001; Vector Laboratories) and 1.5% hydrogen peroxide to remove endog-
enous peroxidase activity. Staining was performed using a rabbit polyclonal 
anti-CD3 zeta (Abcam; 1:100 dilution) as a primary antibody for 1 h at room 
temperature. After this, the sections were extensively washed and incubated 
for 45 min with a biotinylated secondary antibody from the ABC Vectastain 
system (PK-6101; Vector). Brown staining was visualized using 3,3      diamino-
benzidine tetrachloride (peroxidase substrate kit; SK-4100; Vector Labs). 
Immunofl  uorescence was performed on frozen 6-     m sections of the same 
region of the aorta using rat monoclonal anti-TCR (      chain) antibody 
(H57-597; BD Biosciences; 1:100). A PE-conjugated antibody was used for 
detection of fl  uorescence. 
  Measurements of vascular reactivity and O    2        ·     production.     Vascular 
reactivity of aortic rings was measured in organ chambers, as previously de-
scribed (  14  ). Aortic O  2      ·      production was measured by quantifying formation 
of 2-hydroxyethidium from dihydroethidium (25      M) by HPLC. This 
product specifi  cally refl  ects the reaction of O  2      ·      with dihydroethidium and 
has been validated previously (  70  ). Superoxide production by lymphocytes 
was determined using electron spin resonance and the spin probe CAT1-H, 
as previously described (  71  ). 
  Vascular wall morphometry.     Aortic segments were obtained as described 
in Immunohistochemistry and immunofl  uorescence, and sections from 1 mm 
above the diaphragm were stained with hematoxylin and eosin and were 
analyzed using an Axioskop with an AxioCam system and AxioVision 
4.6 software (all from Carl Zeiss MicroImaging, Inc.). Wall thickness was 
measured from the internal to the external elastic lamina at 10 evenly spaced 
sites around the aorta. To determine total cross-sectional wall area, the inter-
nal and external elastic laminas were planimetered and their areas subtracted. 
This diff  erence was reported as cross-sectional wall area. 
  In vitro eff  ect of angiotensin II on T cell activation.     Spleen-derived 
T cells isolated by magnetic sorting as described above were suspended 
in RPMI 1640 with 25 mM Hepes, 1% FBS, 0.1%   l-  glutamine, and 0.1% 
penicillin/streptomycin, with or without 100      M angiotensin II. Cells were 
plated at a density of 2       10  5   per well in 96-well plates precoated with anti-
CD3 (BD Biosciences) and cultured for 3 h at 37  °  C with 5% CO  2  . After in-
cubation, cells were collected, washed with 1% BSA/PBS, and stained using 
anti-CD69  –  FITC, anti-CD4  –  APC, and anti-CD8  –  PerCP. FACS analysis JEM VOL. 204, October 1, 2007 
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